tpeniad

Upload: kimbek-buangke

Post on 08-Jul-2018

216 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/19/2019 tpeniad

    1/23

    1

    Thrombocytopenia

    What we will cover today:Normal platelet production and survival

    Thrombocytopenic bleedingApproach to thrombocytopeniaITP

    DICCases

    April 16, 2 1, Dr! D!"ee

  • 8/19/2019 tpeniad

    2/23

    2

    Thrombocytopoiesis

    PLURIPOTENTSTEM CELL

    COMMITTEDPROGENITOR

    CELL

    RECOGNIZABLEBONE MARROW

    PRECURSOR CELL

    MATUREBLOODCELL

    myeloblastmonoblast

    pronormoblast red cellneutrophilmonocyte

    basophil

    platelet

    CFU-Baso

    CFU-Eos

    CFU-GMBFU-E/CFU-E

    eosinophil

    pre-T

    pre-B

    myeloidproge itor

    !ell

    lymphoid

    lymphoblast

    lymphoblast

    T-cell

    B-cell& plasma cell

    MI"EDPROGENITOR

    CELL

    C#U$Meg mega%aryo!ytepl&ripote t'tem !ell

  • 8/19/2019 tpeniad

    3/23

    3

    Platelet formation

    megakaryocyte formation ofdemarcationmembranes

    platelets

    (pro)platelets

  • 8/19/2019 tpeniad

    4/23

    4

    Platelets in the circulation:Influx, efflux, and redistribution

    CIRCULATINPLAT!L!T"

    "PL!!N

    #!"TRUCTI$Nor R!%$&AL

    PR$#UCTI$N

    platelet count( ) thrombopoietin

    !"#

    $"#

  • 8/19/2019 tpeniad

    5/23

    5

    Thrombopoietin

    increased

    normal

    t(rom)o!ytope ia

    *TPO+ ,ree

    *TPO+total normal

    normal

    ormal platelet !o& t

    platelet

    T%

    plasma

  • 8/19/2019 tpeniad

    6/23

    6

    Thrombocytopenic bleedin'

    #is$ o% bleedingplatelet countcause o% thrombocytopenia

    comorbid diseasedrugs

    Clinical mani%estationspetechiaepurpura, ecchymoses

    mucosal bleedingmenorrhagiaintracranial bleeding

    Ris( of thrombocytopenichemorrha'e in A%L

    )

    *)

    +)

    )

    -)

    ) +) -) .) /) *))

    Platelet count 0x *)123L4

    5 d a y s 6

    i t h ' r o s s

    h e m o r r

    h a ' e

  • 8/19/2019 tpeniad

    7/237

    Approach to thrombocytopenia

    ' aplasia' in iltration' ine ecti e me*a+aryopoiesis e*, M .' selecti e impairment o plateletproduction

    Causes o splenome*aly' in ection' in lammation' con*estion' mali*ancy' red cell disorders' stora*e diseases

    ' immune auto-immune ( T%0 .1E dru*s in ections allo-immune' non-immune sepsis C0 TT%0 2U. hypertensi e disorders o pre*nancy

    loo+ or splenome*aly bone marro3 in esti*ationre ie3 meds

    loo+ or underlyin* disordersre ie3 meds

    T-ROMBOC.TOPENIA

    r&le o&t p'e&dot(rom)o!ytope ia

    SE/UESTRATION PRODUCTION DESTRUCTION

  • 8/19/2019 tpeniad

    8/238

    ITP

    idiopathic autoimmune plateletdestruction

    &1 cause o% isolated thrombocytopenia inother'ise healthy young personsa diagnosis o% e(clusion

  • 8/19/2019 tpeniad

    9/239

    ITP: Clinical features

    occurs in any age or se(, but typicallyyoung %emale

    can be preceeded by viral in%ectionsigns and symptoms depend on plateletcountonset usually insidious

  • 8/19/2019 tpeniad

    10/23

    10

    ITP: Laboratory features

    ITP I) A DIA*N+)I) + -.C"/)I+Nno sensitive and speci0c test %or ITP

    isolated thrombocytopeniaincreased Pnormal PT, PTT

    bone marro' investigation not essential instraight%or'ard cases

  • 8/19/2019 tpeniad

    11/23

    11

    ITP: TreatmentPatient is not bleedin'

    plt 3 4 5 #( not indicatedplt 2 4 5 #( usually not needed, monitor

    closelyplt 7 2 5 #( indicated 'ith one or more o%5prednisoneI I*

    anti D i% #h possplenectomy i% relapsing severe ITP

    8No role %or prophylactic platelet trans%usion, even i% plt 9 :

  • 8/19/2019 tpeniad

    12/23

    12

    ITP: TreatmentPatient is bleedin'

    or serious bleeding 8eg! CN),retroperitoneal, *I:

    Prednisone and I I* Trans%use plateletsconsider urgent splenectomyProvide other supportive;resuscitative care as needed

  • 8/19/2019 tpeniad

    13/23

    13

    ITP: Pro'nosis

    Children5 usually permanent remission

    Adults5 usually relapsing 8chronic ITP:, butcourse is relatively benign!

  • 8/19/2019 tpeniad

    14/23

    14

    #isseminated Intra7ascularCoa'ulation 0#IC4

    DIC is characteri

  • 8/19/2019 tpeniad

    15/23

    15

    Causes of #IC

    In%ection bacterial sepsis, viralin%ections

    Neoplasm A ", adenocarcinoma+bstetrical disorders retained dead %etus,abruption, etc

    Trauma;surgery brain in=ury, crush, burns, etc!

    +thers acute hemolytic trans%usionreaction, etc!

  • 8/19/2019 tpeniad

    16/23

    16

    depletion of clotting factorsprolonged PT, PTT

    increased FDP and D-dimer

    thromboctyopenia (consumption)

    LA8$RAT$R9%ANI !"TATI$N"

    microangiopathic hemolytic anemia

    decreased fibrinogen

    depletion of physiologic anticoagulants

    tissue factor release

    activation of intrinsicpathway of coagulation

    (systemic thrombingeneration)

    generali ed intravascular fibrin deposition

    underlying disorder

    activation offibrinolytic system(systemic plasmin

    generation)

    PAT;$P;9"I$L$ IC!&!NT"

    Pathophysiolo'y of #IC

    hemorrhage

    thrombosis!infarction

    CLINICAL%ANI !"TATI$N"

  • 8/19/2019 tpeniad

    17/23

    17

    Treatment of #IC

    treat the underlying diseasereplacement therapy

    cryoprecipitatePplatelet concentratepac$ed red cells

    consider additional pharmacologic therapycontroversial or investigational agents> AT, APC, PC concentrate, heparin, anti0brinolytic

    agents!

  • 8/19/2019 tpeniad

    18/23

    18

    The most important stuff toremember:

    Approach to thrombocytopeniaITP diagnosis and management

    ?hen to 'orry about a lo' platelet count

  • 8/19/2019 tpeniad

    19/23

    19

    Thrombocytopenia: Case *

    A previously healthy 23 year old female competitive lacrosse player presents to your office with a three day history of increased ruisin! and petechiae" #er only medications are napro$en and anoral contraceptive" %hysical e$am shows petchiae on the le!s andseveral small ruises on the e$tensor surfaces"

    &eu'ocytes ($ 10 9)&* 6"8 +4"0 , 11"0-#emo!lo in (!)&* 130 +120,160-

    ./ (f&* 87 +80 , 100-%latelet count ($ 10 9)&* 11 +150 , 450-.% (f&* 12.5 +7"4 ,10"4-

  • 8/19/2019 tpeniad

    20/23

    20

    Thrombocytopenia: Case *

    #ow do you approach this pro lem dia!nostically

    #ow you mana!e this patient and what do you advise hera out her activities and medications

  • 8/19/2019 tpeniad

    21/23

    21

    Thrombocytopenia: Case +A / / comes ac' on a 75 year old man who is new to your practice"

    &eu'ocytes ($ 10 9)&* 3.6 +4"0 , 11"0-#emo!lo in (!)&* 127 +140 , 180-./ (f&* 101.5 +80 , 100-%latelet count ($ 10 9)&* 56 +150 , 450-.% (f&* 8"1 +7"4 ,10"4-

    eticulocytes ($ 10 9)&* 86 +18 , 94-

    eutrophils ($ 10 9)&* 1.3 +2,7"5"0-

    &ymphocytes ($ 10 9)&* 1"6 +1"5,4"0-.onocytes ($ 10 9)&* 0"7 +0"2,0"8-

    osinophils ($ 10 9)&* 0 +0,0"7-asophils ($ 10 9)&* 0 +0,0"1-

    o platelet clumps are seen on the peripheral lood film"

  • 8/19/2019 tpeniad

    22/23

    22

    Thrombocytopenia: Case +What is the differential diagnosis?

    12 folate deficiencyhypersplenismalcoholmedicationsmyelodysplasiaother one marrow patholo!y

    How do you sort this out?

    tain a history and e$amine the patient"ltrasound of the a domen (spleen si e*"

    :erum 12 / folate one marrow investi!ation"

  • 8/19/2019 tpeniad

    23/23

    23

    Thrombocytopenia

    What we hopefully have covered today:Normal platelet production and survival

    Thrombocytopenic bleedingApproach to thrombocytopeniaITP

    DICCases